About Cornerstone Therapeutics
Cornerstone Therapeutics is a company based in Cary (United States) founded in 2003 was acquired by Chiesi Pharmaceuticals in February 2014.. The company has 318 employees as of December 31, 2022. Cornerstone Therapeutics has completed 2 acquisitions, including Cardiokine and EKR Therapeutics. Cornerstone Therapeutics operates in a competitive market with competitors including aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others.
- Headquarter Cary, United States
- Employees 318 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$30 M (USD), Debt – Conventional
Jul 02, 2012
- Investors
-
Employee Count
318
as on Dec 31, 2022
-
Investments & Acquisitions
Cardiokine
& 1 more
-
Acquired by
Chiesi Pharmaceuticals
(Feb 04, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cornerstone Therapeutics
- Total Funding Total Funding
- Total Rounds 1
- Last Round Debt – Conventional — $30.0M
-
First Round
First Round
(02 Jul 2012)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2012 | Amount | Debt – Conventional - Cornerstone Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cornerstone Therapeutics
Cornerstone Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Chiesi Pharmaceuticals. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of drugs for respiratory, neonatology, rare disease and special care therapeutic areas
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cornerstone Therapeutics
Cornerstone Therapeutics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cardiokine and EKR Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Oncology supportive care and generic products are manufactured and commercialized.
|
2005 | ||||
|
Pharmaceuticals for cardiovascular disease prevention and treatment are developed.
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cornerstone Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cornerstone Therapeutics Comparisons
Competitors of Cornerstone Therapeutics
Cornerstone Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein biologics are developed for treating rare diseases.
|
|
| domain | founded_year | HQ Location |
Precision medicines for lung-related diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of inflammatory and rare diseases
|
|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of respiratory diseases such as cystic fibrosis
|
|
| domain | founded_year | HQ Location |
Therapies for respiratory-related cardiopulmonary disorders are developed.
|
|
| domain | founded_year | HQ Location |
Respiratory disease drugs for asthma and COPD are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cornerstone Therapeutics
When was Cornerstone Therapeutics founded?
Cornerstone Therapeutics was founded in 2003 and raised its 1st funding round 9 years after it was founded.
Where is Cornerstone Therapeutics located?
Cornerstone Therapeutics is headquartered in Cary, United States. It is registered at Cary, North Carolina, United States.
How many employees does Cornerstone Therapeutics have?
As of Dec 31, 2022, the latest employee count at Cornerstone Therapeutics is 318.
What does Cornerstone Therapeutics do?
Cornerstone acquired by Chiesi Farmaceutici SpA is a pharmaceutical firm with five marketed products. The products include ZYFLO, an orally ingested treatment for asthma, CARDENE (nicardipine), an injected treatment for hypertension, CUROSURF which is a lung surfactant used for the treatment of Respiratory Distress Syndrome (RDS) in infants, PERTZE that is used to treat exocrine pancreatic insufficiency (EPI), BETHKIS another CF-related treatment (for Pseudomonas aeruginosa - PA) and generic version of Tussionex (an allergy treatment).
Who are the top competitors of Cornerstone Therapeutics?
Cornerstone Therapeutics's top competitors include aTyr Pharma, ReCode Therapeutics and Pulmatrix.
How many acquisitions has Cornerstone Therapeutics made?
Cornerstone Therapeutics has made 2 acquisitions, including Cardiokine, and EKR Therapeutics.
Who are Cornerstone Therapeutics's investors?
Cornerstone Therapeutics has 1 investor. Key investors include Chiesi Pharmaceuticals.